Ironwood Pharmaceuticals (IRWD) Receivables - Other (2010 - 2020)

Ironwood Pharmaceuticals (IRWD) has 11 years of Receivables - Other data on file, last reported at $73.4 million in Q1 2020.

• For the quarter ending Q1 2020, Receivables - Other rose 5.88% year-over-year to $73.4 million; the trailing twelve-month figure through Mar 2020 stood at $73.4 million (up 5.88% YoY), and the FY2019 full-year result was $106.0 million, up 76.61% from the prior year.
• Receivables - Other retreated to $73.4 million in Q1 2020, from $106.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $106.0 million in Q4 2019 to a low of $50.0 million in Q1 2017.
• A 5-year average of $68.3 million and a median of $65.7 million in 2018 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other soared 99.62% in 2016 and dropped 27.18% in 2018, its largest moves.
• Tracing IRWD's Receivables - Other over 5 years: stood at $63.9 million in 2016, then advanced by 23.59% to $79.0 million in 2017, then retreated by 24.1% to $60.0 million in 2018, then jumped by 76.73% to $106.0 million in 2019, then slumped by 30.73% to $73.4 million in 2020.
• Business Quant data shows IRWD's Receivables - Other at $73.4 million in Q1 2020, $106.0 million in Q4 2019, and $94.6 million in Q3 2019.